Eptifibatide
Links shared publicly online about this topic
Extended-Infusion Eptifibatide to Prevent Stent Thrombosis in a Patient Undergoing Orthopedic Surgery -- Lizza and Kauflin 45 (5): e28 -- The Annals of Pharmacotherapy
theannals.com — “Extended-Infusion Eptifibatide to Prevent Stent Thrombosis in a Patient Undergoing Orthopedic Surgery -- Lizza and Kauflin 45 (5): e28 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on May 11, 2011 at 10:08 pm By:
Extended-Infusion Eptifibatide to Prevent Stent Thrombosis in a Patient Undergoing Orthopedic Surgery: OBJECTIVE... http://bit.ly/kzol9E
SEPIA-ACS1: Otamixaban in ACS
theheart.org — “UPDATED // Intermediate doses of the new factor Xa inhibitor showed trends toward reduced event rates with a similar rate of bleeding compared with heparin/eptifibatide in this phase 2 study.” View full resource at theheart.org
Most Recently Shared on August 30, 2009 at 6:19 am By:
heartwire: SEPIA-ACS1 TIMI 42: Mixed results for otamixaban in ACS http://bit.ly/27E2NM
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty - Drugs.com MedNews
drugs.com — “More than one-fifth of patients on dialysis who undergo angioplasty are given blood thinners they should not be given, new research shows. As a result, these pa” View full resource at drugs.com
Most Recently Shared on December 9, 2009 at 9:28 pm By:
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty - http://bit.ly/6Cw9av
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty - US News and World Report
health.usnews.com — “Some docs not following FDA directive urging against use of Lovenox, Integrilin, study shows” View full resource at health.usnews.com
Most Recently Shared on December 9, 2009 at 1:22 pm By:
20% of Dialysis Patients Get Wrong Blood Thinners for Angioplasty http://bit.ly/8vY8bj /via @Quantros
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty:
health.msn.com — “Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty:” View full resource at health.msn.com
Most Recently Shared on December 8, 2009 at 10:55 pm By:
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty: http://bit.ly/51p9Lq
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty - US News and World Report
health.usnews.com — “Some docs not following FDA directive urging against use of Lovenox, Integrilin, study shows” View full resource at health.usnews.com
Most Recently Shared on December 9, 2009 at 1:14 pm By:
Chris Bethell Health Executive
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty http://bit.ly/8vY8bj By Amanda Gardner, Healthday News
Dialysis patients get contraindicated meds in PCI
theheart.org — “Labeling on eptifibatide and enoxaparin advises against their use in dialysis patients, but for a range of reasons, these drugs are still used, despite the fact that safer alternatives exist, experts say.” View full resource at theheart.org
Most Recently Shared on December 8, 2009 at 9:18 pm By:
One in five dialysis patients undergoing PCI get contraindicated meds . . . with more bleeding http://bit.ly/53oeYL #heartwire
Cardiology Medical News about Myocardial Infarction
mdlinx.com — “Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 3:44 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevatio... http://bit.ly/bvj950 #cardio #mdlinx
Cardiology Medical News about Acute Coronary Syndrome
mdlinx.com — “Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 8:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous C... http://bit.ly/aX2x7L #cardio #mdlinx
Resuscitation on #MDlinx
mdlinx.com — “Resuscitation on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 18, 2010 at 9:03 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide: Resuscitation http://bit.ly/9rfju2 #ER
Cardiology News & Articles - MDLinx - Coronary Artery Disease on #MDlinx
mdlinx.com — “Cardiology News & Articles - MDLinx - Coronary Artery Disease on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 28, 2010 at 9:14 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention: JACC - Jour... http://bit.ly/9tDJNo #cardio #mdlinx
TCT: Last Word Positive on Trial of Bivalirudin (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The final report from the HORIZONS-AMI trial revealed an increasing mortality benefit for ST-elevation MI patients treated with bivalirudin (Angiomax) -- compared with those who received unfractioned heparin plus abciximab (ReoPro) or eptifibatide (Integrelin), according to the trial's lead investigator.” View full resource at qualitypointtech.net
Most Recently Shared on September 27, 2010 at 3:48 pm By:
TCT: Last Word Positive on Trial of Bivalirudin (CME/CE): WASHINGTON (MedPage Today) -- The final report from the ... http://bit.ly/aEZCGI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
